BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21696638)

  • 1. Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma.
    Kagaya A; Shimada H; Shiratori T; Kuboshima M; Nakashima-Fujita K; Yasuraoka M; Nishimori T; Kurei S; Hachiya T; Murakami A; Tamura Y; Nomura F; Ochiai T; Matsubara H; Takiguchi M; Hiwasa T
    Proteome Sci; 2011 Jun; 9(1):31. PubMed ID: 21696638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma.
    Shimada H; Shiratori T; Yasuraoka M; Kagaya A; Kuboshima M; Nomura F; Takiguchi M; Ochiai T; Matsubara H; Hiwasa T
    BMC Cancer; 2009 Jul; 9():232. PubMed ID: 19604354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma: a possible new serum marker for esophageal cancer.
    Shimada H; Kagaya A; Shiratori T; Nomura F; Takiguchi M; Matsubara H; Hiwasa T
    J Gastroenterol; 2009; 44(7):691-6. PubMed ID: 19407926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in chemosensitivity against anticancer drugs by an esophageal squamous cell carcinoma SEREX antigen, AISEC.
    Hiwasa T; Shimada H; Kuboshima M; Shiratori T; Kagaya A; Nabeya Y; Sugano S; Ochiai T; Matsubara H; Takiguchi M
    Int J Oncol; 2009 Mar; 34(3):641-8. PubMed ID: 19212668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
    Shimada H; Kuboshima M; Shiratori T; Nabeya Y; Takeuchi A; Takagi H; Nomura F; Takiguchi M; Ochiai T; Hiwasa T
    Int J Oncol; 2007 Jan; 30(1):97-103. PubMed ID: 17143517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
    Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
    Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.
    Kuboshima M; Shimada H; Liu TL; Nakashima K; Nomura F; Takiguchi M; Hiwasa T; Ochiai T
    Int J Oncol; 2006 Feb; 28(2):463-8. PubMed ID: 16391802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma.
    Kuboshima M; Shimada H; Liu TL; Nomura F; Takiguchi M; Hiwasa T; Ochiai T
    Cancer Sci; 2006 May; 97(5):380-6. PubMed ID: 16630135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma.
    Nakashima K; Shimada H; Ochiai T; Kuboshima M; Kuroiwa N; Okazumi S; Matsubara H; Nomura F; Takiguchi M; Hiwasa T
    Int J Cancer; 2004 Dec; 112(6):1029-35. PubMed ID: 15386348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
    Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
    Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of serum anti-striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers.
    Ito M; Hiwasa T; Oshima Y; Yajima S; Suzuki T; Nanami T; Sumazaki M; Shiratori F; Funahashi K; Takizawa H; Kashiwado K; Tochigi N; Shimada H
    Mol Clin Oncol; 2021 Nov; 15(5):237. PubMed ID: 34650804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.
    Kobayashi S; Hiwasa T; Arasawa T; Kagaya A; Ishii S; Shimada H; Ito M; Suzuki M; Kano M; Rahmutulla B; Kitamura K; Sawabe Y; Shin H; Takiguchi M; Nomura F; Matsubara H; Matsushita K
    Oncotarget; 2018 Apr; 9(26):18559-18569. PubMed ID: 29719626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
    Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
    Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer.
    John T; Caballero OL; Svobodová SJ; Kong A; Chua R; Browning J; Fortunato S; Deb S; Hsu M; Gedye CA; Davis ID; Altorki N; Simpson AJ; Chen YT; Monk M; Cebon JS
    Clin Cancer Res; 2008 Jun; 14(11):3291-8. PubMed ID: 18519755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
    Sumazaki M; Shimada H; Ito M; Shiratori F; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Takizawa H; Kashiwado K; Shin H; Kishimoto T; Matsushita K; Kobayashi S; Nakamura R; Shinmen N; Kuroda H; Zhang XM; Wang H; Goto KI; Hiwasa T
    Cancer Sci; 2020 Dec; 111(12):4453-4464. PubMed ID: 32939876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
    Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
    J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
    Ikeda K; Terashima M; Ishida K; Okamoto K; Suzuki S; Murakami K; Ohtsu T; Suzuki K; Niitsu Y; Obonai H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and fundamental study of a squamous cell carcinoma related antigen (SCC-RA) for esophageal squamous cell carcinoma].
    Ikeda K
    Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):387-96. PubMed ID: 1870566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a panel of autoantibody against NSG1 with CEA, CYFRA21-1, and SCC-Ag for the diagnosis of esophageal squamous cell carcinoma.
    Zheng Q; Zhang L; Tu M; Yin X; Cai L; Zhang S; Yu L; Pan X; Huang Y
    Clin Chim Acta; 2021 Sep; 520():126-132. PubMed ID: 34119530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.